Skip to main navigation Skip to search Skip to main content

The first case of pseudomonas aeruginosa bacteremic pneumonia in a cancer patient receiving pegfilgrastim

  • Fujiko Morita
  • , Yuji Hirai
  • , Kiyozumi Suzuki
  • , Yuki Uehara
  • , Kazunori Mitsuhashi
  • , Masahito Takahashi
  • , Sumio Watanabe
  • , Toshio Naito

Research output: Contribution to journalArticlepeer-review

Abstract

A single dose of pegfilgrastim or the daily administration of colony-stimulating factors can be used to prevent febrile neutropenia. This may delay the detection of rapidly progressive infections among cancer patients undergoing chemotherapy. We report a case of Pseudomonas aeruginosa bacteremic pneumonia that occurred in a patient receiving pegfilgrastim.

Original languageEnglish
Pages (from-to)2039-2042
Number of pages4
JournalInternal Medicine
Volume56
Issue number15
DOIs
Publication statusPublished - 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'The first case of pseudomonas aeruginosa bacteremic pneumonia in a cancer patient receiving pegfilgrastim'. Together they form a unique fingerprint.

Cite this